Feedback / Questions
FPA-154 - Inhibrx
FPA-154: Submission of IND in 2018
(Five Prime Therap)
-
Aug 12, 2017 -
Q2 FY 2017 Results
IND
•
Oncology
http://investor.fiveprime.com/common/download/download.cfm?companyid=AMDA-24F834&fileid=953122&filekey=0152013B-9AFB-4BA9-8D3E-93823D85891C&filename=Five_Prime_Earnings_Update_2Q17_8.8.17.pdf
Aug 12, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious